Oramed Pharmaceuticals Inc.
ORMP
$2.33
$0.031.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | 0.00 | 674.00K | 1.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | 0.00 | 674.00K | 1.34M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 0.00 | 0.00 | 674.00K | 1.34M |
| SG&A Expenses | 6.46M | 6.43M | 7.52M | 8.47M | 8.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.78M | 13.06M | 12.87M | 14.20M | 17.11M |
| Operating Income | -12.78M | -13.06M | -12.87M | -13.52M | -15.77M |
| Income Before Tax | -15.92M | 7.16M | 22.38M | 10.23M | 5.09M |
| Income Tax Expenses | 3.18M | 2.77M | 1.63M | -- | -- |
| Earnings from Continuing Operations | -19.10 | 4.39 | 20.75 | 10.23 | 5.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 43.00K | 73.00K | 112.00K | 223.00K | 437.00K |
| Net Income | -19.06M | 4.47M | 20.86M | 10.46M | 5.53M |
| EBIT | -12.78M | -13.06M | -12.87M | -13.52M | -15.77M |
| EBITDA | -12.59M | -12.85M | -12.65M | -13.31M | -15.57M |
| EPS Basic | -0.47 | 0.11 | 0.51 | 0.26 | 0.13 |
| Normalized Basic EPS | -0.18 | -0.19 | 0.04 | -0.14 | -0.16 |
| EPS Diluted | -0.49 | 0.10 | 0.50 | 0.25 | 0.13 |
| Normalized Diluted EPS | -0.19 | -0.20 | 0.04 | -0.14 | -0.16 |
| Average Basic Shares Outstanding | 163.36M | 163.21M | 162.76M | 162.03M | 161.23M |
| Average Diluted Shares Outstanding | 164.72M | 165.58M | 165.13M | 163.76M | 162.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |